Enovis to Participate in Investor Conferences in November
Enovis Corporation (NYSE: ENOV) has announced participation in two investor conferences this November.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Enovis Corporation (NYSE: ENOV) has announced participation in two investor conferences this November. CFO Chris Hix and incoming CFO Ben Berry will speak at the Credit Suisse 31st Annual Healthcare Conference on November 8 in Rancho Palos Verdes, CA. Later, on November 29, CEO Matt Trerotola and Ben Berry will participate in the Evercore ISI 5th Annual HEALTHCONx virtual conference. Enovis specializes in medical technology and is committed to improving patient outcomes through innovative solutions.
Details
News Market Reaction – ENOV
The recorded move for ENOV in the trading session of this news was +2.23%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Wilmington, DE, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will participate in two investor conferences in November.
On Tuesday, November 8, Chris Hix, CFO, and Ben Berry, incoming CFO, will participate in the Credit Suisse 31st Annual Healthcare Conference in Rancho Palos Verdes, CA.
On Tuesday, November 29, Matt Trerotola, CEO, and Ben Berry, incoming CFO, will participate in the Evercore ISI 5th Annual HEALTHCONx virtual conference.
ABOUT ENOVIS
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.
Contact:
Derek Leckow
Vice President, Investor Relations
Enovis Corporation
+1-302-252-9159
investorrelations@enovis.com
***
Source: Enovis Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.